190 related articles for article (PubMed ID: 20922561)
1. IVIg attenuates TLR-9 activation in B cells from SLE patients.
Kessel A; Peri R; Haj T; Snir A; Slobodin G; Sabo E; Rosner I; Shoenfeld Y; Toubi E
J Clin Immunol; 2011 Feb; 31(1):30-8. PubMed ID: 20922561
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
3. B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells.
Yehudai D; Snir A; Peri R; Halasz K; Haj T; Odeh M; Kessel A
Scand J Immunol; 2012 Oct; 76(4):371-7. PubMed ID: 22725135
[TBL] [Abstract][Full Text] [Related]
4. Response to ODN-CpG by B Cells from patients with systemic lupus erythematosus correlates with disease activity.
Zorro S; Arias M; Riaño F; Paris S; Ramírez LA; Uribe O; García LF; Vásquez G
Lupus; 2009 Jul; 18(8):718-26. PubMed ID: 19502268
[TBL] [Abstract][Full Text] [Related]
5. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
6. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
[TBL] [Abstract][Full Text] [Related]
7. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.
Lenert P; Brummel R; Field EH; Ashman RF
J Clin Immunol; 2005 Jan; 25(1):29-40. PubMed ID: 15742155
[TBL] [Abstract][Full Text] [Related]
8. CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro.
Néron S; Boire G; Dussault N; Racine C; de Brum-Fernandes AJ; Côté S; Jacques A
Arch Immunol Ther Exp (Warsz); 2009; 57(6):447-58. PubMed ID: 19866343
[TBL] [Abstract][Full Text] [Related]
9. Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides.
Zeuner RA; Klinman DM; Illei G; Yarboro C; Ishii KJ; Gursel M; Verthelyi D
Rheumatology (Oxford); 2003 Apr; 42(4):563-9. PubMed ID: 12649404
[TBL] [Abstract][Full Text] [Related]
10. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
11. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
Brummel R; Lenert P
J Immunol; 2005 Feb; 174(4):2429-34. PubMed ID: 15699180
[TBL] [Abstract][Full Text] [Related]
12. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
13. TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase.
Séité JF; Guerrier T; Cornec D; Jamin C; Youinou P; Hillion S
J Autoimmun; 2011 Nov; 37(3):190-7. PubMed ID: 21689906
[TBL] [Abstract][Full Text] [Related]
14. Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.
Graham KL; Lee LY; Higgins JP; Steinman L; Utz PJ; Ho PP
Autoimmunity; 2010 Mar; 43(2):140-55. PubMed ID: 19845477
[TBL] [Abstract][Full Text] [Related]
15. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells.
Blaas SH; Stieber-Gunckel M; Falk W; Obermeier F; Rogler G
Clin Exp Immunol; 2009 Mar; 155(3):534-40. PubMed ID: 19220839
[TBL] [Abstract][Full Text] [Related]
16. Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.
Tsao JT; Hsieh SC; Chiang BL; Yu CL; Lin SC
Clin Exp Med; 2012 Sep; 12(3):153-8. PubMed ID: 22057691
[TBL] [Abstract][Full Text] [Related]
17. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
18. Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.
Gies V; Schickel JN; Jung S; Joublin A; Glauzy S; Knapp AM; Soley A; Poindron V; Guffroy A; Choi JY; Gottenberg JE; Anolik JH; Martin T; Soulas-Sprauel P; Meffre E; Korganow AS
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515028
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.
Giordani L; Quaranta MG; Marchesi A; Straface E; Pietraforte D; Villani A; Malorni W; Del Principe D; Viora M
Clin Exp Immunol; 2011 Mar; 163(3):346-53. PubMed ID: 21175593
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.
Lepse N; Land J; Rutgers A; Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Rheumatology (Oxford); 2016 Jan; 55(1):162-72. PubMed ID: 26320128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]